Company / Accounts Receivable
Entera Bio Ltd. Accounts Receivable History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$126.0K
FY2024
5-year range
$0 / $246.0K
FY2021-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $246,000 to $126,000 over the past 2 years.
Based on SEC 10-K filings.
$126,000 in FY2024 with a 3-year CAGR of -11.7%.
Declined from $246,000 to $126,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -11.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -11.7%, indicating a declining trend.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $126.0K | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $246.0K | +34.4% |
| FY2021 | $183.0K | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026